optimizing the efficacy of t-cell based immunotherapies
Published 2 years ago • 109 plays • Length 1:48Download video MP4
Download video MP3
Similar videos
-
2:41
cell avidity as a predictor of t-cell efficacy
-
0:43
developing an avidcar platform to improve t-cell activity
-
1:07
optimizing car-t therapy: regulating car t-cells in vivo
-
1:02
the use of car-t cell products in a real-world setting
-
0:37
the mechanism of treatment resistance in aml: do cd8-expressing t-cells become exhausted?
-
2:10
optimizing car-t therapy in lbcl
-
9:25
mgus diagnosis: a step-by-step approach
-
12:05
how to clean/change biobase hematology valves
-
28:36
who myeloid neoplasms part 1 updates ii who hematology 5th e update ii review article (proposed)
-
2:05
alnuctamab: improved route of administration and optimized dose level & dosing schedule
-
8:57
outcomes of sct in t-all and t-lbl
-
1:47
identifying positive regulators of t cell functions to improve cellular therapies
-
2:29
epitope editing enables the use of novel immunotherapies for aml
-
3:08
welcome to the video journal of hematology & hematological oncology 🎥🩸
-
4:24
investigating production failure and out-of-specification production of car t-cell therapeutics
-
1:32
factors contributing to the pathogenesis of icaht
-
1:05
the future of immuno-oncology
-
5:42
promising therapeutic efficacy of ebv-specific t-cell immunotherapy tabelecleucel in ptld
-
0:59
developing lsc-targeting agents in aml: progress and current therapeutic capacity
-
1:30
evaluating the optimal duration of cpx-351 treatment & best timing for allosct consolidation in aml
-
2:33
novel immunotherapies in aml and insights into the future of the treatment landscape